ESC 2019

17-32 of 43

Almost significant effects on CV outcomes with ARNI in HFpEF
Almost significant effects on CV outcomes with ARNI in HFpEF
ESC 2019
Almost significant effects on CV outcomes with ARNI in HFpEF
- Prof. Dirk Jan van Veldhuisen, MD
LDL-c lowering with twice-a-year injection of siRNA against PCSK9: The ORION-11 trial
LDL-c lowering with twice-a-year injection of siRNA against PCSK9: The ORION-11 trial
ESC 2019
LDL-c lowering with twice-a-year injection of siRNA against PCSK9: The ORION-11 trial
- Prof. John Kastelein, MD
The 2019 ESC/EAS Dyslipidemia Guidelines from the point of view of the European Atherosclerosis Society
The 2019 ESC/EAS Dyslipidemia Guidelines from the point of view of the European Atherosclerosis Society
ESC 2019
The 2019 ESC/EAS Dyslipidemia Guidelines from the point of view of the European Atherosclerosis Society
- Prof. Alberico Catapano, PhD
Rationale for the lower LDL-c targets in the 2019 ESC/EAS Dyslipidemia Guidelines
Rationale for the lower LDL-c targets in the 2019 ESC/EAS Dyslipidemia Guidelines
ESC 2019
Rationale for the lower LDL-c targets in the 2019 ESC/EAS Dyslipidemia Guidelines
- Prof. François Mach, MD
Long-term treatment with dual antiplatelet therapy in patients with diabetes and stable CAD
Long-term treatment with dual antiplatelet therapy in patients with diabetes and stable CAD
ESC 2019
Long-term treatment with dual antiplatelet therapy in patients with diabetes and stable CAD
- Prof. Ph. Gabriel Steg, MD
Large community-based studies stress the impact of preventive measures
Large community-based studies stress the impact of preventive measures
ESC 2019
Large community-based studies stress the impact of preventive measures
- Prof. Salim Yusuf
Reduction in bleeding with genotype-guided strategy for choice of P2Y12i in STEMI patients
Reduction in bleeding with genotype-guided strategy for choice of P2Y12i in STEMI patients
ESC 2019
Reduction in bleeding with genotype-guided strategy for choice of P2Y12i in STEMI patients
A one-hour hs-troponin protocol in ACS suspected patients resulted in more rapid discharge
A one-hour hs-troponin protocol in ACS suspected patients resulted in more rapid discharge
ESC 2019
A one-hour hs-troponin protocol in ACS suspected patients resulted in more rapid discharge
- Prof. Derek Chew
Importance of continuous use of secondary prevention therapy after CABG
Importance of continuous use of secondary prevention therapy after CABG
ESC 2019
Importance of continuous use of secondary prevention therapy after CABG
All-cause mortality benefit with ICD use in STEMI patients treated with primary PCI
All-cause mortality benefit with ICD use in STEMI patients treated with primary PCI
ESC 2019
All-cause mortality benefit with ICD use in STEMI patients treated with primary PCI
CVD in women
CVD in women
ESC 2019
CVD in women
- Prof. Cecilia Linde
Primary PCI is the best strategy for STEMI patients compared to fibrinolysis
Primary PCI is the best strategy for STEMI patients compared to fibrinolysis
ESC 2019
Primary PCI is the best strategy for STEMI patients compared to fibrinolysis
- Michael Maeng, MD
The diabetes challenge for cardiologists: The key things to understand
The diabetes challenge for cardiologists: The key things to understand
ESC 2019
The diabetes challenge for cardiologists: The key things to understand
- Prof Naveed Sattar, MD
Clear results with NOAC monotherapy in patients with CAD and AF
Clear results with NOAC monotherapy in patients with CAD and AF
ESC 2019
Clear results with NOAC monotherapy in patients with CAD and AF
- Prof. Freek Verheugt
10-year outcomes with CABG versus PCI in patients with three-vessel disease or left main CAD
10-year outcomes with CABG versus PCI in patients with three-vessel disease or left main CAD
ESC 2019
10-year outcomes with CABG versus PCI in patients with three-vessel disease or left main CAD
No beneficial effects of oxygen use in subjects with a heart attack
No beneficial effects of oxygen use in subjects with a heart attack
ESC 2019
No beneficial effects of oxygen use in subjects with a heart attack
- Prof. Ralph Stewart

2/3

17-32 of 43

Title

Share on ReachMD